← FDA Drug Approvals (Drugs@FDA)

PREVACID NAPRAPAC 375 (COPACKAGED)

NDA · New Drug Application · Sponsor: TAKEDA PHARMS NA · Approved 2003-11-14

Drug application

FDA Application #
NDA021507
Application type
New Drug Application
Brand name
PREVACID NAPRAPAC 375 (COPACKAGED)
Generic name
Lansoprazole
Active ingredients
LANSOPRAZOLE; NAPROXEN
Dosage form
CAPSULE, DELAYED REL PELLETS, TABLET
Route
ORAL
Marketing status
Discontinued
Sponsor
TAKEDA PHARMS NA
First approval
2003-11-14

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown